ncRNA name
hsa_circ_0000677
Specific or universal ncRNAs
Specific ncRNAs
Class
Circular RNA
Biomarker
Yes
Biomarker application
Treatment
Upstream regulatory factors
Not available
Downstream target
Wnt/Ī²-catenin signaling pathway
Cancer name
Osteosarcoma
Cancer site
Bone, Articular Cartilage
Treatment type
Chemotherapy
Drug
Cisplatin
Impact of wild-type ncRNA on chemotherapy resistance
Impact of knockdown of ncRNA on chemotherapy resistance
Impact of overexpression of ncRNA on chemotherapy resistance
Up
ncRNA differential expression in
cancer
patients vs. healthy people
Up
Number of patients
Not available
Male patients
Not available
Female patients
Not available
Age range and number
Not available
PMID
Description
Upregulation of circ_001569 significantly promoted osteosarcoma cell resistance to cisplatin by activating Wnt/Ī²-catenin signaling pathway. Thus, these results indicated that circ_001569 represented a novel potentially therapeutic target of osteosarcoma.
Tissue resource
primary osteosarcoma tissue samples and adjacent non-cancerous bone tissue samples
human osteosarcoma cell lines MG-63
human osteosarcoma cell lines U2OS
normal human osteoblastic cell lines hFOB
Experiment
qRT-PCR,Western blot
Institute
Affiliated Hospital of Weifang Medical University
Type Culture Collection of the Chinese Academy of Sciences
Country
China
Continent
Asia